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Book Reviews
Drug Testing in the Workplace
Robert DeCresce, et al.
The Bureau of National Affairs, Inc.
Washington, D.C.
1989/300 pp. Hardcover $45
Drug Testing: A Workplace
Guide To Designing Practical Policies
and Winning Arbitrations
Lloyd Loomis
The Bureau of National Affairs, Inc.
Washington, D.C.
1990/300 pp. Paper, $95
plus appendices
While most of the literature in this expanding area of the law is outdated
before it is published, the best works will contain something of lasting
value. This is especially true of Drug Testing in the Workplace by
Robert DeCresce, Mark Lifshitz, Adrianne Mazura and Joseph Tilson,
released in 1989 by BNA Books. Drug Testing in the Workplace was
written prior to the U.S. Supreme Court's landmark decisions in Skinner
v. Railway Labor Executives Association, 109 S.Ct. 1402 and National
Treasury Employees Union v. Von Raab, 109 S.Ct. 1348, both decided on
March 21, 1989; accordingly, the book's discussion of the legal context
of drug testing, and the policies affecting employers and unions, while
valuable as a springboard for research, is rapidly losing its direct ap-
plicability. By contrast, the lengthy chapter addressed to the science of
drug testing (Chapter 3) and the shorter chapter on the chemistry and
psychopharmacology of selected drugs (Chapter 4), are among the best in
the available legal literature, and are likely to remain so for a considerable
period of time.
The particular value of these two chapters, which comprise almost one
quarter of a very slim book, lies in their utility in preparing for examination
and cross-examination of expert witnesses in employee drug cases. The
following excerpt, taken at random from the discussion of amphetamines
in Chapter 4, illustrates the point:
The EMIT assay is broadly cross-reactive for many
sympathomimetic amines, the most important of which
are ephedrine and phenylpropanolamine. These
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decongestants are used in numerous over-the-counter
cold, allergy and diet preparations such as Nyquil,
Primatene Mist, Coricidin, Vicks Formula 44D,
Robitussin, Sucrets, Dexatrim, Alka-Seltzer Plus,
Alerest and Bayer's children's capsules. False positive
results could occur for about 12 hours after a dose if the
urine is acidic; with an alkaline urine positive results
might persist for several hours longer. An optional
EMIT amphetamine confirmation kit will usually
eliminate interferences caused by ephedrine and
phenylpropanolamine. Phenylephrine and pseudo-
ephedrine may also cross-react in the EMIT assay,
according to the manufacturer. They are present in
products such as Sudafed, Robitussin PE, Chlor-
Trimeton, and Dristan. In contrast, the FPIA assay for
amphetamines shows little, if any, cross-reactivity with
over-the-counter cold preparations containing
phenylpropanolamine or ephedrine.
Phenethylamine, a product of urine decomposition,
may accumulate in specimens after 1 or 2 days. In order
to prevent this product from forming and falsely
evaluating results, urine should be refrigerated and
preserved with 1% sodium fluoride if testing is delayed.
Specimens can be stored in this manner for up to one
year. Last, the presence of glucose in the urine may
cause false positive results with EMIT.
(p. 109)
The influential National Institute on Drug Abuse Guidelines for
Federal Workplace Drug Testing (April 1988) are reprinted as the final
chapter of Drug Testing in the Workplace.
Drug Testing: A Workplace Guide to Designing Practical Policies and
Winning Arbitrations, principally authored by Lloyd Loomis and issued
by BNA as a special report, will find its largest audience among manage-
ment-side labor lawyers involved in the process of designing or negotiat-
ing drug policies, or litigating drug-related employee discipline cases.
More recent than Drug Testing in the Workplace, this paperback volume
cites Consolidated Rail Corp. v. Railway Labor Executives Assoc., 109
S.Ct. 2477, the June 1989 decision allowing Conrail to institute periodic
and return-from-work drug and, alcohol testing without negotiating with
the union. The report summarizes many of the important judicial, NLRB,
and, especially, arbitration decisions relating to drug use, possession, sale,
and testing. It contains an excellent checklist for guiding employers' drug
policies and testing programs. The report discusses a wide variety of
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technical and legal issues. It concludes with an appendix, comprising
almost half the volume, containing the full text of selected arbitration
cases, Federal statutes, guidelines and testing procedures (including those
of HHS and DOT), sample union contracts (the National Master Freight
Agreement and the National Master UPS Agreement) and the full text of
the company policy adopted by Loomis' own employer, the Atlantic
Richfield Company.
Both of these books are highly recommended.
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